|Articles|October 13, 2004
Contrast business prepares for shake-up
Advertisement
Bracco has invested in Chinese facilities to produce and ship contrast media. The investments are being made through a joint venture with Shanghai-based Sine Pharmaceutical. The Bracco-Sine production plant opened in June in Shanghai's high-tech district. It will focus on the final cycle in contrast media production. Chinese workers will formulate drug solutions from basic ingredients sent from Italy, then prepare, seal, and sterilize individual doses.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Meta-Analysis Examines Impact of AI in Radiology for Cancer Detection
2
Philips to Showcase Newly FDA-Cleared Cardiovascular Workspace at RSNA
3
Is MRI Assessment of Right Ventricular Global Longitudinal Strain Prognostic for Heart Failure?
4
Emerging Radiology Platform Offers Access to Variety of CT-Based AI Applications
5

























